In the present article, we describe a mechanistic study of a novel derivative of N-amidino-substituted benzimidazo [1,2-A]quinoline in two human colorectal cancer cell lines differing in p53 gene status. We used a proteomic approach based on two-dimensional gel electrophoresis coupled with mass spectrometry to complement the results obtained by common molecular biology methods for analyzing cell proliferation, cell cycle, and apoptosis.